Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Baricitinib is an effective treatment for severe alopecia areata.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Hair transplant surgery by Follicular Unit Extraction is mostly safe and gives good results with few complications.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

A dermatoscope is important for evaluating hair transplants and managing patient expectations.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

PRP injections improve skin and hair quality, boost self-esteem, and are safe and satisfying for patients.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Trichoscopy is useful for assessing androgenetic alopecia severity but can't determine hair loss stage alone.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.